+ Watch CHTP
on My Watchlist
A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.
This "Hot 1 Star" was added to Zacks.com's "Strong Buy" list today. Zero debt and a Current Ratio of 5.5 are also attractive.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions